\"Vaccines will create an India brand that will go beyond vaccines and pharmaceuticals. We have to capitalise on this goodwill. This should help all sectors. PLI scheme's success will support this,\" the Prime Minister said

In order to ramp up the COVID-19 vaccination capacity, the government is involving a large number of private facilities. The health ministry had said that around 10,000 hospitals under Ayushman Bharat-PMJAY and 687 hospitals under CGHS can be used as CVCs

The interim efficacy trend of 81 per cent, analysed as per the protocol approved by the Drugs Controller General of India, puts it at par with other global front-runner vaccines, stated ICMR

Data from 25,800 participants who received a vaccine or placebo in 1:1 ratio showed that the vaccine was well-tolerated; Bharat Biotech said the trial conducted with ICMR was the largest in India

As senior citizens across the country take part in the vaccination drive, here is all the information they need two know about the two vaccines - Covaxin and Covishield

The researchers, including those from Public Health England (PHE), compared the rate of hospitalisation and deaths in confirmed COVID-19 patients aged over 80 who were vaccinated more than 14 days before testing positive, with unvaccinated cases

\"The real motivation here is actually exfiltrating intellectual property and getting a competitive advantage over Indian pharmaceutical companies,\" says Cyfirma Chief Executive Kumar Ritesh

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, fell 8.9% to 25.62

Once approved, the product can be marketed in the 27 European Union (EU) member countries and European Economic Area (EEA) member states of Norway, Iceland and Liechtenstein

The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states

The project, which was spearheaded by Chandrasekhar, the director, and Raji Reddy, senior scientist from IICT, has been completed in four months, the CSIR said

A total 16,577 infections were reported in a day, while the death toll increased to 1,56,825 with 120 new fatalities

'Operation Bandar' was planned under utmost secrecy and most of the details were only known to the top planners, defence sources have revealed

Wall Street's main indexes fell on Thursday, with the Nasdaq slipping about 2.5%, as technology-related stocks remained under pressure following a rise in U.S. bond yields

To reach that target from the current $42 billion, the Indian pharmaceutical industry will require to double the last decade's growth rate of 6% to 12%

NSE's India VIX, a gauge of the market's expectation of volatility over the near term, fell 5.2 per cent to 22.89. Meanwhile, BSE's market capitalisation stood at Rs 206 lakh crore in today's session

The new variant, known as B.1.526, was first identified in samples collected in New York in November, and by mid-February represented about 12% of cases, researchers at Columbia University Vagelos College of Physicians and Surgeons, said on Wednesday

Stock Market Updates Today: Sectorally, except for IT and pharma index, all the other indices ended with decent gains. Private, PSU Bank and financial indices closed 3% higher today.

The approval to the vaccine without phase-3 efficacy data had drawn severe criticism with the government reiterating its stand that the vaccine was safe to use

Sectorally, gains in FMCG, realty, auto, IT, media and metal index were capped by losses in PSU Banking, financial, private banking and pharma index